Edition:
India

Tigenix NV (TIG.OQ)

TIG.OQ on NASDAQ Stock Exchange Global Select Market

41.02USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$41.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
508
52-wk High
$43.94
52-wk Low
$19.24

Select another date:

Wed, Apr 25 2018

BRIEF-Takeda Says Announces Voluntary And Conditional Public Takeover Bid For Outstanding Shares,Warrants And American Depositary Shares Of Tigenix NV To Commence April 30, 2018

* SAYS ANNOUNCES VOLUNTARY AND CONDITIONAL PUBLIC TAKEOVER BID FOR OUTSTANDING SHARES, WARRANTS AND AMERICAN DEPOSITARY SHARES OF TIGENIX NV TO COMMENCE APRIL 30, 2018 Source text for Eikon: Further company coverage: (Reporting By Chris Gallagher)

BRIEF-Tigenix FY Operating Loss Widens to 53.2 Million Euros

* FY OPERATING LOSS OF EUR 53.2 MILLION VERSUS LOSS OF EUR 3.0 MILLION YEAR AGO

BRIEF-Tigenix And Takeda Announce Alofisel® (Darvadstrocel) Receives Approval To Treat Complex Perianal Fistulas In Crohn's Disease In Europe

* TIGENIX AND TAKEDA ANNOUNCE ALOFISEL® (DARVADSTROCEL) RECEIVES APPROVAL TO TREAT COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE IN EUROPE

BRIEF-Tigenix Says Received Transparency Notification From Jpmorgan Chase & Co​ On Jan 16

* ‍TRANSPARENCY NOTIFICATION PURSUANT TO ARTICLE 14 OF LAW OF MAY 2, 2007​‍

Japan's Takeda to acquire TiGenix for $630 mln

TOKYO, Jan 5 Japan's Takeda Pharmaceutical Co said on Friday it has agreed to buy Belgian biotech group TiGenix NV for 520 million euros ($628 million).

Select another date: